187 related articles for article (PubMed ID: 32348183)
21. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
[TBL] [Abstract][Full Text] [Related]
23. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.
Hiremath S; Akbari A; Shabana W; Fergusson DA; Knoll GA
PLoS One; 2013; 8(3):e60009. PubMed ID: 23555863
[TBL] [Abstract][Full Text] [Related]
24. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
[TBL] [Abstract][Full Text] [Related]
25. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van der Molen AJ; van Ommen GV; Wildberger JE
Eur Radiol; 2020 Jul; 30(7):4005-4013. PubMed ID: 32107605
[TBL] [Abstract][Full Text] [Related]
26. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
27. RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study.
Katoh H; Nozue T; Horie K; Sozu T; Inoue N; Michishita I
Cardiovasc Interv Ther; 2019 Apr; 34(2):105-112. PubMed ID: 29730853
[TBL] [Abstract][Full Text] [Related]
28. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
29. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
30. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
[TBL] [Abstract][Full Text] [Related]
31. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
Torigoe K; Tamura A; Watanabe T; Kadota J
Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
[TBL] [Abstract][Full Text] [Related]
32. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
34. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
[TBL] [Abstract][Full Text] [Related]
35. Safe Hydration Volume to Prevent Contrast-induced Acute Kidney Injury and Worsening Heart Failure in Patients With Heart Failure and Preserved Ejection Fraction After Cardiac Catheterization.
Bei WJ; Wang K; Li HL; Lin KY; Guo XS; Chen SQ; Liu Y; Yi SX; Luo DM; Chen JY; Tan N
J Cardiovasc Pharmacol; 2017 Sep; 70(3):168-175. PubMed ID: 28525419
[TBL] [Abstract][Full Text] [Related]
36. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).
Er F; Nia AM; Dopp H; Hellmich M; Dahlem KM; Caglayan E; Kubacki T; Benzing T; Erdmann E; Burst V; Gassanov N
Circulation; 2012 Jul; 126(3):296-303. PubMed ID: 22735306
[TBL] [Abstract][Full Text] [Related]
37. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
38. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
[TBL] [Abstract][Full Text] [Related]
39. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.
Giacoppo D; Gargiulo G; Buccheri S; Aruta P; Byrne RA; Cassese S; Dangas G; Kastrati A; Mehran R; Tamburino C; Capodanno D
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487354
[TBL] [Abstract][Full Text] [Related]
40. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]